Form 4: Rezolute Director Nerissa Kreher Increases Stake with New Stock and Option Grants
Insider Transaction Report
Rezolute, Inc. Director Nerissa Kreher has reported the acquisition of 9,000 common shares as restricted stock units and 5,000 stock options, aligning her interests further with the company.
Summary
- Nerissa Kreher, a Director of Rezolute, Inc. (RZLT), reported changes in her beneficial ownership of company securities.
- On June 10, 2025, Ms. Kreher acquired 9,000 common shares in the form of restricted stock units (RSUs) at a price of $0 per share.
- These 9,000 RSUs are scheduled to vest 100% on July 1, 2026.
- Following this transaction, Ms. Kreher directly beneficially owns 34,500 common shares.
- Additionally, on June 10, 2025, Ms. Kreher acquired 5,000 Director Stock Options (Right to Buy) at an exercise price of $4.39 per share.
- These 5,000 options also vest 100% on July 1, 2026, and have an expiration date of June 10, 2035.
- Following this transaction, Ms. Kreher directly beneficially owns 5,000 derivative securities (stock options).
Sentiment
Score: 6
Explanation: The sentiment is slightly positive as the grants align the director's interests with shareholders, indicating confidence and commitment, which is generally viewed favorably by the market.
Positives
- The acquisition of additional common shares and stock options by a director indicates increased alignment of management's interests with those of shareholders.
- The grants serve as an incentive for the director to contribute to the long-term success and value creation of Rezolute, Inc.
Future Outlook
The document indicates future vesting events for the granted restricted stock units and stock options on July 1, 2026, and an option expiration date of June 10, 2035.
Industry Context
This Form 4 filing reflects standard compensation practices for directors in publicly traded companies, often involving equity grants to align their interests with long-term shareholder value.
Related Party Transactions
- The reported transactions represent compensation in the form of equity grants from Rezolute, Inc. to Nerissa Kreher, a director of the company, which is a common related-party transaction for executive and director compensation.
Stakeholder Impact
- Shareholders: Increased alignment of a director's financial interests with shareholder value due to equity grants.
- Employees: No direct impact mentioned, but general positive sentiment from director commitment could indirectly benefit morale.
- Management: The grants serve as an incentive for the director, reinforcing commitment to company performance.
Next Steps
- Vesting of 9,000 restricted stock units on July 1, 2026.
- Vesting of 5,000 Director Stock Options on July 1, 2026.
- Potential exercise of stock options by June 10, 2035.
Key Dates
| Date | Description |
|---|---|
| 06/10/2025 | Date of transaction for the acquisition of common shares (RSUs) and Director Stock Options. |
| 07/01/2026 | Vesting date for both the 9,000 restricted stock units and the 5,000 Director Stock Options. |
| 06/10/2035 | Expiration date for the 5,000 Director Stock Options. |
Keywords
Rezolute, RZLT, SEC Form 4, Insider Transaction, Stock Options, Restricted Stock Units, Director Compensation, Equity Grant, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.